---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-22-001571"
form_type: "8-K"
ticker: "SRRK"
cik: "0001727196"
company_name: "Scholar Rock Holding Corp"
filed_at: "2022-11-09T23:59:59+00:00"
generated_at: "2026-06-22T01:37:54.250327+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Scholar Rock appoints Dr. Jing Marantz as CMO, grants 250,000-share option award

## Summary
- Dr. Jing Marantz appointed CMO effective Nov 9, 2022; brings >20 yrs experience in neurology, oncology, rare diseases.
- Base salary $465,000, annual bonus target 40% of base, and inducement stock option for 250,000 shares.
- Option vests 25% on first anniversary, remainder quarterly over 3 years; subject to continuing service.
- Prior roles include EVP/CBO at Krystal Biotech, SVP at Acceleron (Merck) and Alnylam; board member at Arcturus Therapeutics.

## SEC filing metadata
- accession: 0001157523-22-001571
- form_type: 8-K
- ticker: SRRK
- cik: 0001727196
- company_name: Scholar Rock Holding Corp
- filed_at: 2022-11-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1727196/000115752322001571/0001157523-22-001571-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1727196/000115752322001571/a52964704.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-22-001571
- JSON: https://secwatch.observer/filing/0001157523-22-001571.json
- Plain text: https://secwatch.observer/filing/0001157523-22-001571.txt

## Key facts
- Executive change
  Dr. Jing Marantz was appointed as Chief Medical Officer at Scholar Rock Holding Corp.
  - Action: appointed
  - Role: Chief Medical Officer
  source text: appointed Dr. Jing Marantz as Chief Medical Officer effective as of November 9, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1727196/000115752322001571/0001157523-22-001571-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.